Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Research · July 16, 2018

Low-Concentration Atropine for Myopia Progression

Ophthalmology

 

Additional Info

Ophthalmology
Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control
Ophthalmology 2018 Jul 06;[EPub Ahead of Print], JC Yam, Y Jiang, SM Tang, AKP Law, JJ Chan, E Wong, ST Ko, AL Young, CC Tham, LJ Chen, CP Pang

Further Reading